TABLE I Degree of Whole-body Aromatase Inhibition by Drugs Used in Breast Cancer Clinical Efficacy
| Drug |
Dose |
Mean percentage inhibition |
Reference |
|
| Aminoglutethimide (+ hydrocortisone) |
1000 mg (+ 40 mg)/d |
90.6 |
MacNeill et al., 1992 |
| Formestane |
250 mg/2 w (im) |
84.8 |
Jones et al., 1992 |
| Fadrozole |
2 mg/d |
82.4 |
Lonning et al., 1991 |
| Vorozole |
1 mg/d |
93.0 |
Van der Wall et al., 1993 |
| Letrozole |
2.5 mg/d |
> 99.1 |
Geisler et al., 2001 |
| Anastrozole |
1 mg/d |
97.3 |
Geisler et al., 2001 |
| Exemestane |
25 mg/d |
97.9 |
Geisler et al., 1998 |
|
[All analyses, other than Van der Wall et al. (1993) were conducted in the Dowsett laboratory.]